Biocept's trading halt and resumption may cause short-term volatility in the stock price, but it is not clear whether the halt will have a lasting impact on the stock's value. The halt may have been due to a variety of reasons, such as news, order imbalances, or regulatory issues, but the article does not provide any specific information about the cause of the halt.